Clinical Trial Update: UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus [Phase 2]

View source ↗

Summary

Phase II trial of systemic Edmonston strain measles virus (oncolytic virotherapy) for multiple myeloma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Edmonston strain of measles virus (Measles virus (Edmonston strain) oncolytic therapy)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19